NCT00815763View on ClinicalTrials.gov

Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Ischemic Stroke
Interventions
DRUG

ginsenoside-Rd

infusion ginsenoside-Rd 20 mg once a day and continued for 14 day

DRUG

placebo

infusion placebo once a day and continued for 14 day

Trial Locations (1)

710032

the Department of Neurology , Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT00815763 - Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter